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Abstract
Background:  In this study, differential gene expression analysis using complementary DNA
(cDNA) libraries has been improved. Firstly by the introduction of an accurate method of assigning
Expressed Sequence Tags (ESTs) to genes and secondly, by using a novel likelihood ratio statistical
scoring of differential gene expression between two pools of cDNA libraries. These methods were
applied to the latest available cell line and bulk tissue cDNA libraries in a two-step screen to predict
novel tumour endothelial markers. Initially, endothelial cell lines were in silico subtracted from non-
endothelial cell lines to identify endothelial genes. Subsequently, a second bulk tumour versus
normal tissue subtraction was employed to predict tumour endothelial markers.
Results: From an endothelial cDNA library analysis, 431 genes were significantly up regulated in
endothelial cells with a False Discovery Rate adjusted q-value of 0.01 or less and 104 of these were
expressed only in endothelial cells. Combining the cDNA library data with the latest Serial Analysis
of Gene Expression (SAGE) library data derived a complete list of 459 genes preferentially
expressed in endothelium. 27 genes were predicted tumour endothelial markers in multiple tissues
based on the second bulk tissue screen.
Conclusion: This approach represents a significant advance on earlier work in its ability to
accurately assign an EST to a gene, statistically measure differential expression between two pools
of cDNA libraries and predict putative tumour endothelial markers before entering the laboratory.
These methods are of value and available http://www.compbio.ox.ac.uk/data/diffex.html to
researchers that are interested in the analysis of transcriptomic data.
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Background
Study aim
The growth and survival of tumours is dependent on their
ability to obtain a blood supply and damage inflicted on
the tumour endothelium has been shown to effectively
eradicate tumours [1]. It follows that the discovery of
widely expressed tumour endothelial markers promises
much clinical benefit [2]. The aim of this study was to
apply novel bioinformatic methods to the latest public
expression data repositories, with an emphasis on cDNA
library analysis, to create an up to date list of putative
endothelial genes and to predict tumour endothelial
markers that are potential anti-cancer targets.
Previous studies [3-15] have employed cDNA or SAGE
libraries to predict the transcriptional profiles of tissues of
interest that were subsequently confirmed by experimen-
tal analysis. Our analysis [8] employed a cDNA subtrac-
tive Basic Local Alignment Search Tool (BLAST) [16],
algorithm to predict endothelial specific genes. This
approach required cross referencing of the results to SAGE
libraries to confidently predict endothelial expression due
to a large number of false positives associated with the
BLAST method of EST to gene assignment used. In the
study by Ho et al. 2003 [7], Unigene's Digital Differential
Display (DDD) tool was employed to predict endothelial
genes, which is reliant on Unigene clusters. DDD requires
at least 1000 EST sequences from a cDNA library to be
clustered into Unigene clusters for valid statistical analysis
and can measure statistical significance accurately
between only two libraries [15]. This 1000 sequence limit
of DDD can remove small, but often potentially relevant,
cDNA libraries from an analysis.
Improving cDNA library analysis
This study aimed to improve both the statistical analysis
and EST to gene assignment methods used in subtractive
in silico cDNA differential gene expression analyses. To
eliminate the cDNA library false positive discovery rate of
the Huminiecki and Bicknell 2000 [8] study, EST to gene
assignment was improved by combining human genome
position of sequences with a BLAST database search. This
eliminated all EST to gene assignment ambiguity.
In contrast to microarray gene expression data that pro-
duces continuous measures, EST data is in the form of dis-
crete counts and the methods for finding differentially
expressed genes are necessarily different from those used
for microarrays [17]. Methods for EST analysis include the
use of a Poisson model for the EST counts to derive a test
statistic [15,18], a multinomial model leading to a tradi-
tional Chi Squared test [19], or a test conditioned on a
constant total EST count using a hypergeometric or bino-
mial distribution [19]. In contrast, the SAGEmap algo-
rithm [20] computes a posterior distribution for a fold
ratio. A disadvantage of the traditional Chi Squared test
[19] is that it is unreliable when the EST counts are low.
Here, we describe a new likelihood ratio test that is an
extension of the method of Stekel et al. 2000 [15], that
instead of identifying differentially expressed genes across
a set of different libraries, will identify genes that are dif-
ferentially expressed between two groups of libraries;
within the groups the libraries should be the same, but
between groups they may be different. The method
removes the need for the 1000 Unigene cluster limit of the
DDD tool, enables any size cDNA library to be analysed
and accurately determines differential expression across
more than two cDNA libraries. We also compare the
results of our method with the methods of Susko and
Roger [19] and the SAGEmap algorithm [20].
In silico Tumour Endothelial Marker prediction
A two-step analysis was performed to predict tumour
endothelial markers (TEMs). The first stage identified
endothelial genes by comparing the expression patterns of
genes between endothelial and non-endothelial cell lines.
The second stage involved a comparison of bulk tumour
and bulk normal cDNA libraries to identify genes up reg-
ulated in tumours. Putative TEMs are genes that were both
endothelial and preferentially expressed in tumours.
Results
Development of an algorithm for EST to gene assignment
A new algorithm for assigning an EST to a gene has been
developed that takes advantage of the almost complete
human genome and combines it with a BLAST database
search to achieve an accurate result. Initially, two EST
pools and all Reference sequence project (Refseq) [21]
mRNA sequences were aligned to the human genome
using the BLAST like alignment tool (BLAT) [22]. BLAT
was used in preference to BLAST for genome alignments
because of its superior speed. Sequences occupying an
ambiguous position in the genome were removed. The
aligned sequences were then collected into Perl data struc-
tures and a simple custom-clustering algorithm (Jake clus-
ter) assigned each EST to a gene or gene prediction based
on their overlapping genome position. In the BLAST data-
base search, each EST was BLAST searched against a Refseq
database containing human mRNA and gene predictions.
Only the best mRNA hit from the BLAST database search
was assigned to an EST and this was regardless of the e-
value result. The results of BLAT genome alignments and
BLAST database search were then cross-referenced and
accurate EST to gene assignment was made based on the
following decision tree:
1) If genome BLAT mapping and BLAST database results
agreed, then that gene was assigned to the EST regardless
of e-value for the database search.BMC Genomics 2008, 9:153 http://www.biomedcentral.com/1471-2164/9/153
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2) If the results disagreed, then the BLAST result alone was
accepted if the alignment was of high quality, >= 92%
identity with an alignment length of >= 100 bases.
A pictorial representation of the analysis is shown in Fig-
ure 1. The approach was able to assign ESTs to a gene even
when the single pass cDNA sequencing of an EST was of
low quality. Thus, first finding an unambiguous position
in the genome that overlaps with a gene and then search-
ing with BLAST to find the best gene, it was able to assign
an EST to a gene. Further, using a high quality BLAST
alignment alone for the assignment gives this approach
the ability to also assign a gene that lies in a gap in the
human genome sequence.
Validation of the EST to gene assignment algorithm
The results of the BLAST subtraction method used in our
previous work [8] were compared to those of the algo-
rithm developed here. Using a custom relational database
developed in house, cDNA libraries were collected and
divided into 2 pools (endothelial and non-endothelial
cells respectively) and formatted into BLAST databases.
The same data were used in this experiment as used in the
earlier study because the EST to gene BLAST protocol was
dependent on an e-value [23]. The e-value was optimised
in the earlier work for predictive capacity by performing
trial runs. E-values are dependent on the size of a BLAST
database and so it was important to use the same data.
This was possible for the endothelial cell lines as the exact
An overview of the EST to gene assignment process Figure 1
An overview of the EST to gene assignment process. Each EST sequence is BLAST searched against a Refseq mRNA 
database and the best mRNA is assigned that EST. In tandem, a mapping of all ESTs and Refseq mRNA to the human genome 
assigns ESTs to genes based on genome position. A decision tree makes the final assignment based on the quality of alignment 
and agreement between the two methods. If the genome position and BLAST result agree, the EST is assigned, if they do not 
agree but the BLAST result is of high quality (> 92% and > 100 bp alignment) the EST is also assigned. For any other result the 
EST is removed from the analysis.BMC Genomics 2008, 9:153 http://www.biomedcentral.com/1471-2164/9/153
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11,117 ESTs were collected, however, for the non-
endothelial pool the EST count had increased from
173,137 to 178,653 as a result of further EST sequencing.
The expected value for the non-endothelial pool was kept
at 10e-20 as the larger pool size made the e-value more
stringent and less likely to deliver false positive hits.
Although there was a good agreement between the old
BLAST and combined method EST assignments for some
genes, a problem with searching mRNA queries against an
EST database is that any EST is able to hit more than one
gene using an e-value cut-off. In reality this is not possible,
as an EST is derived from a single transcript derived from
a single gene. Table 1 shows the number of EST sequences
that hit more than one gene for both EST to gene assign-
ment methods. From the endothelial pool using the ear-
lier [8] method there were 5,228 from the 11,117 ESTs
that were assigned to more than one gene using an e-value
cut-off of 10e-30. The ambiguous assignment means that
it is not possible to know which EST to gene assignment
was correct without manual inspection and as such failed.
Assuming the remaining 5,889 ESTs that hit only one
gene were correctly assigned, this amounted to a 53% suc-
cess rate. For the new combined algorithm there were no
EST sequences assigned to more than one gene and the
success rate for EST to gene assignment from the endothe-
lial pool was 91%.
Testing of statistical significance
To measure statistical significance of differential gene
expression using cDNA libraries there is the DDD tool
available at Unigene. This tool employs the Fisher exact
test [24] to measure statistical significance (P < 0.05)
between two libraries. According to [15] the statistics used
by DDD are not valid for measuring statistical significance
across multiple but only between two cDNA libraries. A
further requirement of DDD is that it is only valid for
cDNA libraries that contain at least 1000 sequences col-
lected into Unigene clusters. Several endothelial cell line
libraries used in this study contained less than 1000
sequences and comparisons between more than two
libraries were required. For these reasons, the DDD tool
and Unigene clusters were of no use in this analysis.
The statistics in the analyses used here combine a general-
ised likelihood ratio test with a False Discovery Rate
(FDR) that accounts for the different size of the cDNA
library pools. During cDNA library construction, bacterial
colonies are picked at random from agar plates for single
pass sequencing of the EST insert. This process is random
and can be modelled by a Poisson distribution. To derive
the appropriate statistical method, two hypotheses were
compared with each other. The Null Hypothesis is that
there is no difference in gene expression between two
cDNA library pools and any differences in gene expression
are due to sampling errors from the picking of colonies.
Alternatively, the difference in gene expression could be
due to a genuine biological effect. The likelihood ratio sta-
tistic (R-statistic) is derived by dividing the likelihood of
seeing the data under the null hypothesis by the likeli-
hood of seeing the data under the alternative hypothesis.
For the latest endothelial cDNA library data two p-values
were generated. The first p-value can be derived from the
R-statistic because 2R is asymptotically Chi Square distrib-
uted. The second was generated using a randomization
method similar to the one used in Stekel et al. 2000. It
should be noted that multiple testing on all genes in the
human genome and using either of these p-values would
result in many false positives. To account for multiple test-
ing errors, a False Discovery Rate adjusted (FDR-adjusted)
procedure was employed [25]. A q-value [26] of 0.01 rep-
resents 1% false discovery rate and means that 10 in 1000
significantly differentially expressed genes were false pos-
itives. A q-value of 0.01 was considered significant in this
work. For comparison we have also included Bayesian
posterior probabilities as used in the SAGE xProfiler tool
[20] and a method from Susko and Roger 2004 [19].
Application of the statistics to the analysis
Applying the new analysis and statistics to the original
data used by [8], 14 genes were predicted significantly
endothelial specific and a further 160 (Additional file 1)
were significantly up regulated in endothelial cells. Table
2 lists the 14 predicted significantly endothelial specific
genes.
It is of interest to compare the 16 predicted endothelial
genes listed in table 7 of the original Huminiecki and
Table 1: A comparison of EST to gene assignment methods
Endothelial EST pool count ESTs unambiguously 
assigned to a gene
ESTs assigned to more than 
1 gene
% success rate for the total 
pool
Huminiecki and Bicknell [8] 11,117 5,889 5,228 53
Method described here 11,117 10,153 0 91
A comparison of the two EST to gene assignment methods using the same data. The new method of EST to gene assignment improved accuracy 
enabling a higher percentage of ESTs to be unambiguously assigned compared to the Huminiecki and Bicknell method [8].BMC Genomics 2008, 9:153 http://www.biomedcentral.com/1471-2164/9/153
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Bicknell 2000 [8] analysis with those found here. Three of
the original 16 genes were no longer predicted as signifi-
cantly endothelial and Table 3 summarises the results.
RAMP2 had no ESTs in either pool; COL4A1 was up regu-
lated in endothelial cells but not to significance with a q-
value of 0.5. In contrast, RASIP1 was endothelial specific
with a single EST found in the endothelial pool but absent
from the non-endothelial pool. However, the q-value of
0.36 was again not statistically significant.
Three genes identified as endothelial specific in the origi-
nal analysis were not found to be so here. ROBO4 hit the
EST [GenBank:AA577940] from the library
NCI_CGAP_HSC1 that is a flow-sorted and non-normal-
ized bone marrow cDNA library. EST accession [Gen-
Bank:AI380234] hit CD93 that is from a B-cell, chronic
lymphocytic leukaemia flow-sorted cell line
(NCI_CGAP_CLL1), while vWF hit a non-endothelial EST
from the NCI_CGAP_Br4 library [GenBank:AA721546].
The last library was prepared from micro-dissected nor-
mal breast duct tissue and in view of the extensive litera-
ture showing restriction of von Willibrand factor
expression to endothelium, is presumably from endothe-
lial contamination of the dissected tissue. In subsequent
Table 2: Endothelial specific genes found using the original data
Gene FDR q-value Endothelial ESTs Non-endothelial ESTs
ECSM2 0.0000 9 0
TFPI 0.0000 7 0
MMRN1 0.0000 5 0
TIE1 0.0000 5 0
ACTA1 0.0000 5 0
ECSM1 0.0002 4 0
CD34 0.0002 4 0
BMX 0.0031 3 0
LOC650049 0.0031 3 0
APLN 0.0031 3 0
DUS4L 0.0031 3 0
FABP4 0.0031 3 0
LOC643977 0.0031 3 0
PAQR3 0.0031 3 0
A list of predicted endothelial specific genes using the new EST to gene assignment and statistical methods but with the original cDNA library data 
from Huminiecki and Bicknell [8]. 14 genes were predicted as significantly endothelial specific. A further 160 genes were predicted as showing 
significantly upregulated endothelial expression (q-value <= 0.01) (additional file 1) but were not endothelial specific (i.e. had EST hits in the non-
endothelial pool). With the new analysis there was no longer a need to cross reference to SAGE libraries for accurate prediction.
Table 3: Comparison of methods with table 7 from Huminiecki and Bicknell (2000)
Gene FDR q-value Endothelial ESTs Non-endothelial ESTs Original Unigene ID
ECSM2 0.0000 9 0 Hs.30089
MMRN1 0.0000 5 0 Hs.268107
ECSM1 0.0002 4 0 Hs.13957
FABP4 0.0031 3 0 Hs.83213
RASIP1 0.3696 1 0 Hs.233955
RAMP2 - 0 0 Hs.155106
VWF 0.0000 27 1 Hs.110802
CD93 (ECSM3) 0.0022 4 1 Hs.8135
ROBO4 (ECSM4) 0.0022 4 1 Hs.111518
CDH5 0.0022 4 1 Hs.76206
EDN1 0.0000 7 2 Hs.2271
SDPR 0.0001 6 2 Hs.26530
PECAM1 0.0000 24 5 Hs.78146
EFEMP1 0.0000 40 8 Hs.76224
COL4A1 0.5598 4 16 Hs.119129
CTGF 0.0000 30 49 Hs.75511
Listing of the genes from Table 7 of our earlier work [8] and how they came out in the new analysis. 13 of the 16 genes were significantly 
endothelial; however, non-endothelial hits to known endothelial genes showed that the choice of non-endothelial cell lines could be improved. q-
values in bold denote a significance threshold of <= 0.01.BMC Genomics 2008, 9:153 http://www.biomedcentral.com/1471-2164/9/153
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analyses the non-endothelial pool was refined to exclude
such hits.
Current data with the new algorithm and statistics, 
experiment 1
Employing the new EST assignment algorithm and the
novel statistical method, a similar subtractive screen to
Huminiecki and Bicknell 2000 [8] was carried out but this
time with the most recent publicly available data. In the
earlier 2000 study there were 11,117 endothelial EST
sequences. This has now increased to 31,114 and 64% of
the currently available endothelial cell data was new.
Table 4 lists the endothelial cell libraries used.
In view of aberrant gene expression by carcinoma lines
arising from genetic instability and endothelial contami-
nation of libraries isolated by Fluorescence-activated cell
sorting (FACS) or micro-dissection, a non-endothelial
pool with no carcinoma cell, flow sorted or micro-dis-
sected lines (136,336 ESTs, Additional file 2) was con-
structed (experiment 1).
Additional file 3, parts 1–3, shows the ranking of results
using the different p-value methods and the posterior
probability. The top 10 endothelial genes differ greatly
between methods and is biologically intuitive with the
Chi squared derived q-values rather than with the rand-
omization generated q-values or the Susko and Roger sta-
tistics [19]. Of potential concern might be low EST counts
giving significant results, where Chi Squared statistics
might normally be considered unreliable.
An example is the already validated endothelial gene TEK,
which has 4 endothelial ESTs to 0 none-endothelial ESTs.
The p-value given by the randomization method, for
which the low counts are not a problem, is more signifi-
cant than that given using the Chi Squared approxima-
tion. Since our primary concern is minimizing false
positive (Type 1) errors, and the Chi Squared approxima-
tion is behaving more conservatively than the randomiza-
tion method, we can confidently report that these genes
are differentially expressed despite the small number of
ESTs observed. In comparison, both the posterior proba-
Table 4: Latest endothelial libraries available at Genbank
New/Original cDNA library Count
Original Stratagene endothelial cell 937223 7173
Original Aorta endothelial cells, TNF alpha-treated 1908
Original Aorta endothelial cells 1245
Original Human endothelial cells, large insert, pCMV expression library 859
Original Umbilical vein endothelial cells II 404
Original Human aortic endothelium 20
Original HDMEC cDNA library 12
Original Umbilical vein endothelial cells I 9
Original Human endothelial cell (Y. Mitsui) 3
New PUAEN2 9382
New Sugano cDNA library, coronary artery endothelial cell 4707
New VESEN1 1316
New VESEN2 1173
New HEV PCR-select 1049
New UMVEN2 433
New Human Endothelial cells 346
New Sugano cDNA library, umbilical vein endothelial cell 342
New PUAEN1 326
New UMVEN1 167
New CAE 88
New Human umbilical vein Endothelial Cell cDNA library 48
New Sugano cDNA library, endothelial cell 28
New Human umbilical vein cord 15
New IMS_CAS 15
New Human umbilical venous cord 12
New HUVEC cDNA Library 12
New HUVEC Subtracted Library 1 8
New Plasmid subtractive library of human umbilical vein endothelial cells (HUVEC) stimulated by lipopolysaccharide 8
New IMS_CAE 4
New Homo sapiens umbilical vein 2
Total 31114
Genbank endothelial cDNA libraries that were used in this study. 21 new libraries have been submitted since our 2000 analysis [8]. The 30 
combined libraries incorporate 31,114 endothelial ESTs.BMC Genomics 2008, 9:153 http://www.biomedcentral.com/1471-2164/9/153
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bility [20] and Susko and Roger [19] methods both pro-
duced an insignificant result for this gene. Additional files
4, 5, 6 and 7 show the full results of experiment 1 ranked
using the four different statistical methods. It is of interest
to note that the posterior probability score using a target
fold difference factor of 2 was the most conservative statis-
tic producing a list of 424 genes with a posterior probabil-
ity cut-off of >= 0.9. In contrast the randomization
generated q-values produced 661 significant genes (q-
value <= 0.01), the Susko and Roger method 536 and the
Chi Square q-values 554 significant genes. We chose to
use the Chi Square q-values in all subsequent analyses as
this gave the greatest prediction of validated endothelial
genes.
From a cDNA library endothelial subtraction analysis
alone (experiment 1) using the Chi Squared generated q-
values there were 431 genes (Additional file 8) that were
significantly up regulated in endothelial cell lines. Of
these, 104 genes showed an endothelial specific profile
(Table 5), as transcripts were absent in the non-endothe-
lial pool. The gene with the most significant endothelial
specific profile was the metallo-proteinase gene MMP1, a
surprising result as literature suggests this gene is widely
expressed [27,28]. Based on this literature, it is possible
that a fibroblast cell line added to the non-endothelial
pool would help to improve the analyses but human lung
fibroblasts used for in the Real time PCR in this work and
showed no MMP1 expression (Figures 2 and 3). It is also
worthy of note that MMP1 is also up regulated in
endothelial cells according to SAGE library analysis in
experiments 2 and 3. There are currently 13 endothelial
SAGE libraries in the public domain and 11 of them
express MMP1 at a high level. The average tag count for
MMP1 was 216 tags and the median 180 tags. Therefore,
although the literature suggests MMP1 is not specific to
endothelial cells, the current available SAGE data shows
MMP1 to be highly expressed in endothelial cells. The lit-
erature also shows MMP1 to have a critical role [29-31].
This analysis also predicted ROBO4, CD93 and VWF as
endothelial specific genes.
cDNA and SAGE library analysis combined, experiment 2
The SAGE library screen was very similar to the cDNA
library approach as it involved comparing two pools of
SAGE library cell lines using the SAGEmap xProfiler tool.
Although the problem is the same, to find differentially
expressed genes, the statistical methods used by Lash et al.
[20] differ to this Poisson approach used here as it
employs Bayesian statistics. These authors do not reject
the null hypothesis that gene expression between two
pools of libraries is equal, they estimate the probability
that gene expression differs by a fold factor which is
dependent on an assumed probability density function
f(x). For a full description consult the article on SAGEmap
paper [20].
For the second experiment, the data from the cDNA anal-
ysis of experiment 1 was combined with SAGE in the same
way as the 2000 analysis. The SAGE analysis used the lat-
Table 5: Endothelial specific genes from cDNA library analysis with latest data
Gene FDR q-value Endothelial ESTs Non-endothelial ESTs
MMP1 0 203 0
ROBO4 0 130 0
SPARCL1 5.21E-70 97 0
VWF 1.33E-52 73 0
HHIP 6.58E-44 61 0
C9orf26 1.60E-23 33 0
RHOJ 4.68E-22 31 0
BMX 2.45E-21 30 0
ELTD1 1.26E-20 29 0
MMRN1 1.84E-18 26 0
EMCN 5.17E-17 24 0
CDH5 2.75E-16 23 0
SOX7 3.94E-14 20 0
ARHGAP24 1.03E-12 18 0
FGD5, PCDH12 1.03E-12 18 0
CD93 5.37E-12 17 0
ERG, MYCT1 2.64E-11 16 0
FLJ22746 1.28E-10 15 0
SELE 6.56E-10 14 0
ANGPT2, TCF4 3.36E-09 13 0
EDG1 1.68E-08 12 0
This table shows the top 24 genes from the 104 genes in the human genome with the most endothelial specific expression profile predicted by 
applying the new analysis to the latest cDNA libraries. The other 80 endothelial specific genes are in additional file 8.BMC Genomics 2008, 9:153 http://www.biomedcentral.com/1471-2164/9/153
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Real time PCR analysis of randomly chosen endothelial predicted genes across a range of cell types Figure 2
Real time PCR analysis of randomly chosen endothelial predicted genes across a range of cell types. Real time 
PCR was carried out on the predicted endothelial genes ECSM2, MMP1, SOX18, ERG, RHOJ and APLN. The graphs illustrate 
the power of the bioinformatics models as all genes examined were up regulated or specific to HUVECs and/or HDMECs.BMC Genomics 2008, 9:153 http://www.biomedcentral.com/1471-2164/9/153
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Real time PCR analysis of randomly chosen endothelial predicted genes across a range of cell types Figure 3
Real time PCR analysis of randomly chosen endothelial predicted genes across a range of cell types. Real time 
PCR was carried out on predicted endothelial genes MMRN2, STAB1, LYL1, ELTD1, EFEMP1 and BMX. The graphs illustrate 
the power of the bioinformatics models as all genes examined were up regulated or specific to HUVECs and/or HDMECs.BMC Genomics 2008, 9:153 http://www.biomedcentral.com/1471-2164/9/153
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est endothelial libraries against a pool of normal non-
endothelial libraries (Additional file 9). There were 10
endothelial cell line SAGE libraries containing 427,254
tags and 74% of the SAGE library data was new since 2000
and submitted to SAGEmap [20]. Results are presented in
Additional file 10 that lists 27 endothelial genes.
cDNA and SAGE library analysis combined (including 
carcinoma cell line cDNA data), experiment 3
Although cancer, micro-dissected and sorted libraries in
non-endothelial cell lines were thought to contaminate
and invalidate the analysis, there exist many of these
libraries in the public domain. Thus, to maximise the
chance of predicting a comprehensive set of endothelial
genes, a final experiment (experiment 3) was performed
using non-endothelial libraries that included cancer,
micro-dissected and sorted libraries (178,653 ESTs and
733,461 SAGE tags, Additional file 11). The SAGEmap
xProfiler analysis was again combined with a cDNA
library subtraction. 58 endothelial genes were predicted
from this analysis (Additional file 12).
A comprehensive set of in silico predicted endothelial 
genes
Combining the results of all three analyses gave a non-
redundant list of 459 genes preferentially expressed at a
statistically significant level in endothelial cells (Gene
symbols in Additional file 13).
Experimental validation of the endothelial gene prediction
Real time PCR was carried out on predicted endothelial
genes to examine the predictive power of the in silico
analyses. A random selection of genes was PCR amplified
from human umbilical vein endothelial cells (HUVECs),
human dermal micro-vascular endothelial cells
(HDMECs) and a selection of normal primary, non-
endothelial isolates; human lung fibroblasts (MRC-5),
human bronchial epithelial cells (HBEC), adult human
epidermal keratinocytes, peripheral blood lymphocytes
and hepatocytes. Total RNA was extracted and Real time
PCR was performed to measure differential expression of
these genes between the cell types. Figures 2 and 3 show
the power of the bioinformatics models as all genes exam-
ined were up regulated or specific to HUVECs and/or
HDMECs. Namely, ECSM2, MMP1, SOX18, ERG, RHOJ,
APLN, MMRN2, STAB1, LYL1, ELTD1, EFEMP1 and BMX.
Tumour endothelial marker prediction
Following the prediction of endothelial genes, a second
screen was performed to identify genes up regulated in
tumours or foetal tissue. Bulk tissue cDNA libraries that
contain endothelium were used. All bulk tissue libraries
used are in Additional files 14 to 28. The subtraction pro-
cedure carried out compared bulk tumour with bulk nor-
mal cDNA libraries from the same organ or tissue. The
analysis involved six tissues, namely, lung, brain, colon,
kidney, prostate and skin. Three foetal tissues (lung, brain
and kidney) were also screened since foetal tissues, like
tumours, have active angiogenesis. By screening each tis-
sue independently, the analysis was able to identify genes
that were putatively up regulated in a tissue specific fash-
ion. Special attention was taken in choosing normal tissue
libraries, to ensure that they contained no active angio-
genesis (e.g. foetal libraries were avoided for the normal
tissue pools). Genes that were both selectively or preferen-
tially expressed in tumour or foetal tissues and preferen-
tially expressed in endothelial cells constituted predicted
TEMs. 27 genes were chosen as being potential TEMs
based on the specific or/and significant up regulation in
multiple tissues (Additional file 29).
Discussion
Identifying differentially expressed genes
The identification of cell or tissue specific genes is of
ongoing interest to the biologist as such genes often per-
form a unique function within that cell or tissue type. In
the past, tissue specific genes were sought using a range of
molecular subtraction techniques employing mRNA/
cDNA from the cell type of interest and a putative 'control'
cell. Examples of such techniques include subtractive
hybridisation, PCR display and PCR select. These
approaches have been highly successful but are laborious
and expensive. More recent approaches have included
selective insertional gene trapping or FACS sorting of cell
lineages labelled with GFP in e.g. zebrafish followed by
gene chip analysis. Both techniques have been used to
identify endothelial genes [32,33], for example in
zebrafish the endothelium and precursors were labelled
with Fli promoter GFP. Nevertheless, such techniques are
still expensive and laborious.
An alternative is to analyse computationally the vast
amount of expression data now available in the public
domain. We performed such an analysis in 2000 [8] that
identified several previously unknown endothelial genes
including Robo4, the endothelial Roundabout guidance
gene. A critical finding in the earlier analysis was the need
to cross reference a cDNA with a SAGE analysis to achieve
accurate prediction of expression. A complementary
approach by Ho [7] combined cDNA and SAGE library
database mining with microarray analysis. Virtual subtrac-
tion was carried out on data in the public domain using
available tools to identify putative endothelial genes.
These genes were then micro-arrayed and probed with
RNA samples from a selection of cultured endothelial and
non-endothelial cell types. The results of Ho et al. are
compared with ours below.
We became aware that these earlier computational tech-
niques could be improved and there are several cogentBMC Genomics 2008, 9:153 http://www.biomedcentral.com/1471-2164/9/153
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reasons for repeating such an analysis now. Firstly, the
large increase in expression data available now compared
to 2000, in particular the number of ESTs in the endothe-
lial libraries has more than doubled. Secondly, following
the publication of the human genome, we have developed
a new technique that combines a BLAST search with
genome BLAT alignments to increase the accuracy of EST
to gene assignment. This removes the ambiguity of EST to
gene assignment and consequent inaccuracies of the
results present in our earlier analysis. Finally, we devel-
oped a novel likelihood ratio statistic analysis that can
identify differentially expressed genes across multiple
cDNA libraries. Using these improvements to cDNA
library analysis and the inclusion of the latest SAGE
library data, we have derived what we consider to be a
near definitive set of endothelial specific genes.
cDNA library analysis improvements
Our earlier analysis [8] showed that endothelial genes are
not reliably predicted using cDNA library analysis alone.
Two possible explanations for this were. 1) Computation-
ally, the EST to gene assignment was inaccurate for some
genes with the BLAST protocol chosen and 2) a statistical
analysis was not applied to the EST counts in order to
determine the significance of the differential gene expres-
sion.
Repeating our method on the cell lines used in the earlier
[8] study validated the new approach. The new analysis
proved the critical importance of accurate EST to gene
assignment to enable a successful analysis using cDNA
libraries alone. The new method produced a successful
assignment of 91% of the ESTs compared with 53% for
the earlier study. Using the 2007, as apposed to the 2000
data, we have 31,114 assigned endothelial ESTs and a suc-
cess rate of 94%. It should be noted that this success rate
is also dependent on the quality of cDNA libraries, but
comparing like for like, the new algorithm improved the
accuracy of assignment by 38%. In order to identify differ-
entially expressed genes between two pools of cDNA
libraries convincingly, it is essential to employ a rigorous
statistical analysis. The method described here makes use
of the intrinsic variability associated with cDNA library
measurements and represents the most powerful statisti-
cal analysis possible associated with that model. We note
that the test is more appropriate than a t-test, and more
powerful than non-parametric statistics such as the Mann-
Whitney test. We also note that differential expression of
cDNA libraries can be performed on line at the CGAP and
Unigene. However, DDD was not used in these analyses
as it does not employ the maximal statistics test and only
performs differential expression between cDNA libraries
that have at least 1000 EST sequences clustered into Uni-
gene as the analysis is invalid with fewer sequences. In
contrast, the likelihood ratio statistics used in these anal-
yses can be applied to cDNA libraries of any size and the
EST to gene assignment does not rely on Unigene clusters.
One feature of our test is that it does not take into account
genes with EST counts of 0 in all libraries. Although such
genes are not observed to be differentially expressed, and
so do not contribute to the FDR as no test has been
applied to them, it is possible for such genes to be truly
differentially expressed but expressed at low levels and so
not seen. It would be possible to extend the test we
describe to take this possibility into account when testing
those genes that are expressed. The likelihood functions
for the null and alternative hypotheses, instead of based
on an unconditional probability, could condition the
probabilities on there being a count of at least 1 in at least
one library. This is unlikely to make a material difference
to the results.
Comparison of the results with previous work
It is of interest to compare the results of this analysis with
two previous bioinformatic analyses to identify endothe-
lial genes, those of Huminiecki and Bicknell [8] and Ho et
al. [7]. In our earlier 2000 study, 16 genes were predicted
as endothelial by a combined SAGE and cDNA library
analysis. From the 16 genes, 13 were also predicted as sig-
nificantly endothelial in this study. The three genes that
differed between the two analyses were COL4A1, RAMP
and RASIP1. In the new analysis RASIP1 was endothelial
specific but not to significance, COL4A1 was expressed in
both cDNA library pools and RAMP was not expressed in
either pool. It is interesting that ECSM2 was the most
endothelial specific gene in the Huminiecki and Bicknell
[8] and Ho et al. [7] studies and was predicted as endothe-
lial here but it was not ranked first, ROBO4 and MMP1
ranked higher. Real time PCR (Figure 3) and in-situ
(unpublished data) show extreme endothelial specificity
for ECSM2 and its lower ranking is simply due to fewer
ESTs, i.e. it is expressed at a lower level in the cDNA librar-
ies. A comparison with the endothelial genes found in this
study with that of Ho et al. [7] reveals 30 of the 49 genes
were predicted as significantly (q-value <= 0.01) up regu-
lated in endothelial cells. A further 5 genes were endothe-
lial specific but not to significance (q-value > 0.01). 14
genes failed to show significant or specific expression in
endothelial cells. Interestingly, the second ranked
endothelial gene from the [7] analysis, SHE, showed only
a single endothelial EST in this analysis. We conclude that
although tissue specific genes can be predicted by cDNA
analysis alone, it is advisable to use as many data sources
as possible in order to derive a comprehensive list of
genes. Finally, our results show that it is better to use nor-
mal cell isolates than carcinoma cell lines or libraries
derived from micro-dissected or FACS sorted cells for this
type of analysis, since several 4characterised endothelialBMC Genomics 2008, 9:153 http://www.biomedcentral.com/1471-2164/9/153
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genes hit ESTs in these non-endothelial libraries (Table 3:
VWF, ROBO4 and CDH5).
Extended analysis to predict tumour endothelial markers
We extended the analysis to identify which of the
endothelial genes were expressed in tumours but not nor-
mal tissue. This was achieved by combining the endothe-
lial screen with an analysis that compared gene expression
between tumour and normal bulk tissue libraries from
several organs. A gene was a predicted TEM if it was pref-
erentially expressed in endothelial cells and tumour tis-
sues but absent in normal tissues. A list of 27 promising
new TEMs based on these analyses is given in Additional
file 29. Each cell in Additional file 29 represents the result
for a tumour/foetal screen for a particular organ. Ulti-
mately, we wanted to find genes that showed tumour and
foetal specific expression in all or most of the organs at a
statistically significant level. Cells with green coloured text
represent this type of result, having 0 ESTs in the normal
pool and a q-value of less than 0.01. Genes showing sig-
nificant and specific expression in multiple organs (brain,
skin, kidney and foetal lung) were PLOD3 and THRAP4.
However, these genes showed expression in normal tissue
for several other organs. Likewise some genes were signif-
icantly up regulated in tumours in multiple organs but
were not specific to tumours (cells in blue). These genes,
although putative TEMs, were considered of least thera-
peutic value, as some expression was evident in normal
tissues and as such they can not be used to specifically tar-
get tumours.
Investigation of a subset of predicted TEMs
As endothelium comprises less than 5% of tumour tissue,
it was hypothesised that genes with a tumour specific
although not statistically significantly different expression
could still be a TEM. Such genes are shown in Additional
file 29 in red text. The most promising TEMs from Addi-
tional file 29 were selected based on little or no expression
in normal tissue across all or multiple organs (red and
green cells). Of these, angiopoietin 2 (ANGPT2), proto-
cadherin 12 (PCDH12) and leucine rich repeat containing
8 family member C (LRRC8C) had expression profiles
completely restricted to tumour or foetal tissues.
ANGPT2, in these in silico results, was restricted to renal
and colon tumour tissue in adults and lung in the embryo.
This result is supported by the literature that indicates
ANGPT2 is associated with tumour endothelium and
tumour progression [34-37]. In contrast, leucine rich
repeat containing 8 family member C was not yet reported
to be a TEM in the literature but rather a gene responsible
for adipocyte differentiation [38]. The 9 putative novel
TEMs with the best tumour profile are listed in Table 6.
The table excludes genes that already have a substantial
literature (e.g. angiopoietin2). A final gene worthy of note
is mediator of RNA polymerase II transcription subunit 28
homolog (S. cerevisiae, MED28): Previous work has
shown MED28 to be significantly up-regulated in
tumours, its over expression is able to stimulate cellular
proliferation and its expression is up-regulated by
endothelial cells when exposed to tumour media [39,40].
TEM experimental validation
In situ hybridisation and immunostaining are the most
definitive direct methods to experimentally validate the
predicted TEMs in Table 6. However, the sensitivity to
optimisation of in situ hybridisation makes it problematic
for high throughput analysis. The second requires anti-
bodies and the time to prepare these slows progress.
Therefore to validate our approach at this time, the next
section describes the analyses and literature search results
for previously predicted tumour endothelial markers.
An assessment of the TEM prediction fidelity based on 
previously validated TEMs
Delta4
Delta4 has been cited to have endothelial specific expres-
sion [41-43] and to be up regulated in tumour vessels
[41,44]. In this study, Delta4 (DLL4) was endothelial spe-
cific but was expressed at a very low level in endothelial
cell cultures. Thus, delta4 matched one EST from the
endothelial pool and none from the non-endothelial
pool, with an FDR-adjusted q-value of 0.28. Even though
Table 6: The top Nine Tumour Endothelial Markers
Gene Product
SPHK1 sphingosine kinase 1 isoform 2
KCTD15 potassium channel tetramerisation domain containing 15
LRRC8C factor for adipocyte differentiation 158
PCDH12 protocadherin 12 precursor
C12orf11 hypothetical protein LOC55726
ECSM2 hypothetical protein LOC641700
GBP4 guanylate binding protein 4
IKBKE IKK-related kinase epsilon
MED28 mediator of RNA polymerase II transcription, subunit 28 homolog
This table lists the top nine tumour endothelial markers from the analyses.BMC Genomics 2008, 9:153 http://www.biomedcentral.com/1471-2164/9/153
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delta4 was not statistically significantly up regulated in
endothelial cells, it showed some evidence of being
endothelial specific as there were no ESTs found from the
non-endothelial pool. DLL4 was found in brain and
colon tumour tissues. However, the expression was not
specific or significant in tumours. Thus, in our analysis
DLL4 was not a predicted TEM.
GPR124
GPR124 (TEM5) was previously identified as a putative
TEM using custom SAGE library analysis [14]. In the cur-
rent analysis, GPR124 failed to match any endothelial
ESTs from the 31,114 EST in the endothelial pool. From
the non-endothelial pool, GPR124 did match a single EST
[GenBank:BF325872] from the AN0041 cDNA library
derived from a normal amniotic fluid cell line. These
results suggest that GPR124 is only expressed at a low
level in normal tissue and is absent or at a very low level
in cultured endothelial cells. In contrast, GPR124 was pre-
dicted as significantly and specifically up regulated in
multiple tumour tissues. Thus, GPR124 appears to be a
tumour but not a tumour endothelial marker.
TEM1
TEM1 (endosialin or CD 248) [14] has a count of 1 and 2
ESTs for the endothelial and non-endothelial pools
respectively. The FDR-adjusted q-value for this gene was
0.61, a non-significant value. One EST from the non-
endothelial pool, accession [GenBank:CN484271] was
from a primary human ocular pericyte cDNA library. This
agrees with experimental findings of MacFadyen et al.
[45,46] that have shown that endosialin is expressed by
fibroblasts and a subset of pericytes associated with
tumour vessels but not by tumour endothelium.
SPARC
Numerous studies have reported SPARC to be up regu-
lated in endothelial cells, to have a role in tissue remodel-
ling and be linked to tumour progression [47-50]. Our
analysis strongly predicted SPARC to be a TEM. SPARC
was up regulated in endothelial cells with a significant q-
value of 8.4 × 10-10 and also significantly up regulated in
brain, colon, kidney and prostate tumour tissue.
ROBO4
Several groups have independently reported ROBO4 as a
TEM [51-53]. In this study ROBO4 was highly endothelial
specific, both from the in silico and experimental analy-
ses. In the tumour screen, ROBO4 was seen to be tumour
specific in brain and kidney tumour tissues but not at a
statistically significant level. Thus ROBO4 was predicted
as a tumour endothelial marker, but not in all tumour
types. In this case our analysis may be under predictive, as
experimentally ROBO4 has been found to be a strong
TEM [52,53].
These results demonstrate the absolute need for experi-
mental verification of bioinformatics predictions and
there is evidence both for and against the use of cDNA
analyses for the prediction of TEMs. If TEM1, TEM5 and
DLL4 are true TEMs then this technique is not 100% reli-
able. Conversely, the successful prediction of ROBO4,
ANGPT2, VIM and SPARC shows that these methods do
have the ability to predict a validated TEM. The novel pre-
dictions of this analysis await future validation.
Differential gene expression analyses using these methods 
through a web tool
A web tool has been developed to enable researchers to
take advantage of these new algorithms and design their
own differential gene expression analysis [54]. As far as
possible, each Human EST from all of the cDNA libraries
at Genbank has been assigned to a Refseq gene or gene
prediction based on the new Jake cluster algorithm so that
any tissue of interest can be queried provided cDNA
libraries exist. The interface lets the user select two pools
of cDNA libraries, group A and group B, to be compared
and produces a list of differentially expressed genes. The
results are returned to the user as a table, reporting the q-
value and whether the gene is up or down regulated in
pool A. It is hoped these new algorithms and statistical
methods will enable the rapid prediction of differentially
expressed genes.
Conclusion
New cDNA library data is continually been submitted to
Genbank and the amount of relevant information that
can be mined is increasing. cDNA library analysis has
been improved in this work by more accurate EST to gene
assignment and the best possible statistics applied to the
data. Using these tools on the latest data sets will lead to
the prediction of new biologically and therapeutically
important genes. This is enhanced by the statistics as
unlike DDD at NCBI, they permit the inclusion of cDNA
libraries of all sizes.
We have shown that these methods accurately predict the
identity of endothelial and tumour endothelial genes by
comparing our results with that of known genes. ROBO4
has consistently been shown to be highly endothelial spe-
cific and was ranked second in this work. TEMs are also
successfully predicted as shown by SPARC and Angiopoe-
itin 2.
It is hoped that biologists will take advantage of these
methods for their disease of interest by using the online
tool. An interface has been designed such that a user can
select tissue, histology, preparation and protocol of inter-
est.BMC Genomics 2008, 9:153 http://www.biomedcentral.com/1471-2164/9/153
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Methods
Construction of databases
A large part of this study involved the collection and
processing of data in the public domain with speed and
accuracy, in particular the creation and use of a Relational
Database Management System (RDBMS) MySQL data-
base called dbestlibraries. The database was central to all
processes in tandem with Perl scripts (see Additional files
30, 31, 32, 33, 34, 35, 36), which were written for the
import of data, assignment of EST to gene symbols and
the accurate calculation of the FDR-adjusted q-value
results. The development of the database involved creat-
ing tables that housed EST information such as library, tis-
sue and accession numbers. This enabled the fast retrieval
of EST accessions for each of the libraries when an analysis
was performed. Other tables stored used were gene, Ref-
seq, Unigene and the results of each SAGE and cDNA
library analysis. Apart from advantages in archiving
results, it also enabled the cross referencing of SAGE and
cDNA results and the assignment of gene symbols etc. See
Additional file 37 for an overview of the table structure of
dbestrlibraries.
Data was collected from Genbank flat files (release 154)
downloaded from the NCBI [55] that supplied all cDNA
library data imported into the database. 10,788 libraries
containing 8,003,786 ESTs were imported into the data-
base. Information concerning 29,367 human reference
sequence project mRNAs and gene predictions were
downloaded from release 14 of the Reference sequence
project [56]. Finally, all information relating to Refseq
sequences was downloaded and imported into the data-
base using data downloaded [57].
Selection of EST library pools
The CGAP library finder [58] was used as a tool for choos-
ing which libraries to compare in tumour and endothelial
screens. Additional endothelial cDNA libraries were dis-
covered, using a Perl script to parse raw Genbank flat files,
which identified libraries with keywords such as "cell
lines" and "endothelial". Normalised or subtracted librar-
ies were excluded from this analysis.
Normal versus tumour tissue screen
Bulk tumour and normal cDNA libraries for 6 organs were
chosen using the CGAP library browser. The combined
algorithm was employed to perform virtual subtraction
hybridisation between tumour and normal libraries of the
same organ. All results were imported into the dbestlibrar-
ies database. Results with an FDR-adjusted q-value of <=
0.01 were significant.
cDNA library screen (EST to gene assignment)
To perform in silico virtual subtraction, two different pro-
tocols for assigning an EST to a gene were combined for
greatest accuracy. The first protocol took advantage of the
almost complete human genome by using genome
address to assign an EST to a gene. A genome address of a
gene or EST is the physical base pair position it occupies
on a chromosome. Both cDNA pools and all Refseq
mRNAs were aligned to the human genome using BLAT to
generate genome addresses. The BLAT alignment genome
addresses were clustered using a Perl algorithm called the
Jake cluster algorithm to identify EST sequences that over-
lapped with a gene and to assign them. To save processing
time using BLAT, the human genome addresses of Refseq
genes and ESTs were downloaded from the University of
California Santa Cruz (UCSC) table browser page [59].
This file contained the pre-processed BLAT output [22].
BLAT is designed to rapidly align DNA sequences that are
95% identical or more, over at least 40 base pairs.
For the second method of assigning an EST to a gene, each
EST from both cDNA library pools was collected as a
FASTA sequence and BLAST searched against a database of
all Refseq mRNAs. A liberal e-value [23] cut-off of 1 was
employed and the -v and -b BLAST options were set to 1.
This ensured that only the best mRNA that matched the
EST was returned in the BLAST results.
A Perl script algorithm (Jake cluster, Additional file 32)
was utilised to combine the results of the genome BLAT
address with the BLAST search method. If the genome
address assignment agreed with the BLAST result, then the
EST was assigned to the gene, if they disagreed, only a high
quality BLAST result allowed EST to gene assignment (>=
92% identity, >= 100 bp alignment).
Combining cDNA and SAGE library analysis
For experiments 2 and 3 described in the results section,
the cDNA analysis was combined with a SAGE library
analysis for endothelial gene prediction. The SAGEmap
xProfiler tool at NCBI was used for this: Available from
the SAGEmap website [20]. No SAGE analyses were car-
ried out for the tumour screen, as there were insufficient
bulk tumour or bulk normal libraries SAGE libraries avail-
able.
For experiments 2 and 3 the SAGE xProfiler analyses were
performed using a fold difference factor of 10 and a 0%
coefficient of variance cut off. Only genes with a posterior
probability of 0.9 or more were considered significant. In
pool "A" (endothelial cell line pool) there were 10 SAGE
libraries containing 427,254 SAGE transcripts. In pool
"B", the normal non-endothelial pool, there were 11 nor-
mal non-endothelial libraries with 329,470 transcripts.
For the cancer cell line non-endothelial pool [8], there
were 24 SAGE libraries consisting of 733,461 transcripts.
As the cancer cell line non-endothelial pool was twice the
size of the normal non-endothelial pool, more genes wereBMC Genomics 2008, 9:153 http://www.biomedcentral.com/1471-2164/9/153
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significantly up regulated in the former due to pool size
and statistics.
Statistical methods
We now describe a statistical methodology for the com-
parison of two groups of cDNA libraries to enable the dis-
covery of differentially expressed genes. The method
combines a likelihood ratio test with a False Discovery
Rate procedure (FDR) in order to provide a robust list of
differentially expressed genes. The analyses extend our
earlier work, which identified differentially expressed
genes in a single group of cDNA libraries [15].
As described in [15], we consider the expression of gene j
in a set of cDNA libraries. There are two groups of librar-
ies:  m  libraries from non-endothelial cell lines, and n
libraries from endothelial cell lines. We let Ni : 1 ≤ i ≤ m be
the number of ESTs sequenced in each non-endothelial
cell line library, and Nm+i : 1 ≤ i ≤ n be the number of ESTs
sequenced in each of the endothelial cell line library. For
each gene j, let xi,j be the number of copies of associated
ESTs in library i.
For each gene, we compare two hypotheses concerning its
frequency of expression in the libraries, using a likelihood
ratio test. Under the null hypothesis, the gene is not differ-
entially expressed and we would expect its frequency to be
identical in both the non-endothelial and endothelial cell
libraries. In contrast, under the alternative hypothesis, the
gene is differentially expressed, and so we would expect
the frequency to be different in the non-endothelial and
endothelial cell lines.
In both cases, as long as the number of copies of ESTs
from the gene is small relative to the total number of ESTs
sequenced in the library, the distribution of the gene is
well approximated by a Poisson distribution. Under the
null hypothesis, the frequency is fj, then for library i, the
number of ESTs is approximately distributed as a Poisson
variable with parameter fiNi. Thus the likelihood function
is
The likelihood estimate of fj under the null hypothesis can
be found by solving:
And the solution fj
(0) is given by:
Equation 3 is simply the proportion of ESTs for the gene
of interest among all ESTs in all of the libraries. Thus
under the null hypothesis, the likelihood function (L0 
j) is
given by equation 1 with f = fj.
For the alternative hypothesis, the frequency of gene tran-
scripts is different in the non-endothelial and endothelial
cell line libraries. By a similar argument, we derive fre-
quencies for each gene j in the non-endothelial libraries
fj
(1) and the endothelial libraries fj
(2) which is given by:
Observe that equations 4 and 5 are very similar to equa-
tion 3, and simply represent the proportion of ESTs for the
gene of interest among all ESTs in the relevant libraries.
Under the alternative hypothesis, the likelihood function
is given by:
And thus the log likelihood ratio is:
Equation 7 can be explained very simply: there are two
terms, one for the non-endothelial libraries and one for
the endothelial libraries. Each term is the log ratio of the
frequency of the gene in the relevant libraries and the
overall frequency of the gene, multiplied by the total
number of ESTs for that gene in the relevant libraries. The
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equation is very similar to the R statistic derived in Stekel
et al. 2000 [15].
Under Wilke's Theorem [60], 2Rj is asymptotically distrib-
uted as a X2 distribution with a 1 degree of freedom. Alter-
natively, a randomization procedure can be used to derive
a p-value not dependent on a X2  approximation as
described in Stekel et al. 2000 [15]. Random data for the
total EST count in the normal and disease libraries are
generating using Poisson distributions with parameters
based on the null hypothesis frequency are generated
1,000,000 times and the R statistic is computed for each
data set. This gives an empirical distribution for the R sta-
tistic against which the value of R from the real data is
compared to generate a p-value. Where several genes
shared the same EST counts, only one distribution was
used, so that these genes would have the same p-values.
However, when analyzing all genes in the library in order
to find those that are most differentially expressed, it is
essential to combine the p-value with a False Discovery
Rate Procedure [25]. Thus the results we present are the
FDR-adjusted q-values [26].
A definition of terms
m = the number of non-endothelial cell line libraries
n = the number of endothelial cell line libraries
xi,j = number of transcript copies of gene j in cDNA library
i
Ni = the total number of clones sequenced in the cDNA
library i
xm+i,j = the number of copies of gene j in the m + i'th cDNA
library
Nm+i = is the total number of clones sequenced in the m +
i'th cDNA library
fj = is the frequency of gene j
Computation of the statistics
To compute the FDR adjusted q-values [26] for a given
data set, we calculate the R-values for all genes. We then
computed the p-values for every gene using both the Chi
Squared value of 2R and the randomization method. The
genes were then ordered according to the p-values, ranked
from smallest to highest. Each p-value was adjusted by
multiplying it by the number of genes in the analysis and
dividing by its rank position (The smallest p-value is rank
position 1). To derive the q-value [26], the list of ranked
values was stepped through, comparing p-value and its
adjusted value and always selecting the lowest.
Calculation of cDNA library Posterior probabilities for 
statistical comparison (experiment 1)
Source code of the SAGEmap xProfiler tool was down-
loaded from the NCBI [61]. All the defaults for the pro-
gram were used except for the c value in statistic which
was set to 3 based on the findings of [62]. The target fold
difference factor was left at 2.
Calculation of cDNA library Susko and Roger statistics
Software and documentation was downloaded from the
Susko and Roger 2004 website [19]. The software was
installed and a Perl wrapper script (Additional file 36) was
used to execute the expr_est differential gene expression
software. In preparation of running this software, all the
non-endothelial and endothelial libraries were combined
into two groups and differential gene expression was
measured between these two groups using the expr_est
software via the Perl wrapper.
Cell isolates and extraction of RNA
Human umbilical vein endothelial cells (pooled
HUVEC), adult human dermal microvascular endothelial
cells (HDMEC), human bronchial epithelial cells (HBEC)
and adult human Epidermal keratinocytes were obtained
from TCS Cellworks (Botolph Claydon, UK). Cells were
grown in their appropriate growth media and supple-
ments, according to manufacturers' instructions and RNA
extracted at passage 2–3. Human lung fibroblasts (MRC-
5) were obtained from the American Type Culture Collec-
tion (Manassas, VA) and cultured in DMEM containing
10% FCS. All cells were grown at 37°C in a humidified
atmosphere of 5% CO2 in air.
Cryopreserved human hepatocytes (TCS Cellworks) were
thawed in Leibovitch L15 medium (Invitrogen, Paisley,
UK), centrifuged and resuspended in fresh media, RNA
was extracted after 30 minutes incubation at 37°C in 5%
CO2. Cryopreserved human peripheral blood lym-
phocytes were obtained from TCS Cellworks, after thaw-
ing they were washed in PBS and used immediately for
RNA extraction.
Quantitative PCR
Total RNA was extracted from cells in culture using TRI
reagent (Sigma, Dorset, UK) cDNA was prepared using a
high capacity cDNA archive kit (Applied Biosystems,
Cheshire, UK). The Universal ProbeLibrary system
(Roche) was used for real time PCR analysis (see Addi-
tional file 38 for primer sequences and Universal probe
numbers). Reactions were performed in triplicate using
Absolute qPCR mix (ABgene, Epsom, UK) according to
manufactures instructions using 10 ng of cDNA.
Reactions were performed in a Rotor-GENE RG30000
thermocycler (Corbett Reaearch, UK) using the followingBMC Genomics 2008, 9:153 http://www.biomedcentral.com/1471-2164/9/153
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cycling conditions; 95°C for 10 minutes followed by 40
cycles of 95°C for 15 seconds and 60°C for 1 minute. The
appropriate housekeeper genes were determined as
described by Vandesompele et al [63] using the software
geNorm. For the cell type screen FLOT2, Ubiquitin C and
B-Actin were used. The raw data was analysed using a
method described by Pfaffl [64].
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